Search PubMedSearch

PubMed · 3340746

Chemonucleolysis.

Abstract

In November 1982, the Federal Drug Administration approved Chymodiactin, chymopapain in injection form, for the treatment of herniated intervertebral discs. This procedure, termed chemonucleolysis, requires radiologic support. This article describes the anatomy, pathology, and special techniques related to chemonucleolysis and defines the role of the radiologic technologist in the completion of this procedure.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Fodor, J C Malott. Chemonucleolysis.. https://pubmed.ncbi.nlm.nih.gov/3340746/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Clinical and ultrastructural analysis of failures in chemonucleolysis.

A series of 12 patients with failed chemonucleolysis were analyzed to determine the various causes of such failures. The ultrastructural findings observed in laminectomy specimens did not account for the failure in the enzyme treatment. The findings suggested deficient cellular nutrition secondary to enzymatic histolysis of the nucleus pulposus.

Chymopapain

Chymopapain.

Explore the source record for details and available documents.

Chymopapain

Contribution of discography to the diagnosis and treatment of lumbar disc herniation.

In this study, based on 600 cases of lumbar disc herniation treated by chemonucleolysis, the authors underline the importance of performing good discography and interpreting its results. A discographic classification of intervertebral disc deterioration is suggested. A CT-discographic study is reported and its results are compared with those of standard discography. On the basis of these studies, the authors have established methodological data concerning the efficacy of chemonucleolysis and its evaluation.

Chymopapain